急性期123I-碘马西尼SPECT显像中的交叉性小脑示踪剂摄取可预测非致死性高血压性壳核或丘脑出血患者3个月功能结局
本研究纳入46例非致死性高血压性壳核或丘脑出血患者,于出血后7天内行123I-碘马西尼(IMZ)早期和晚期SPECT显像,计算小脑半球不对称比(ARcbl)。早期和晚期ARcbl均与3个月改良Rankin量表(mRS)评分相关,多因素分析显示仅晚期低ARcbl与不良功能结局(3个月mRS评分≥3)显著相关。结论认为急性期IMZ SPECT的交叉性小脑示踪剂摄取可预测3个月功能结局。
要点
- 46例非致死性高血压性壳核或丘脑出血患者于出血后7天内行123I-IMZ早期和晚期SPECT显像。
- 早期(ρ=-0.511,P=0.0003)和晚期(ρ=-0.714,P<0.0001)ARcbl均与3个月mRS评分相关。
- 多因素分析显示仅晚期低ARcbl与不良功能结局(3个月mRS评分≥3)显著相关(95%CI 0.001-0.003,P=0.0212)。
核心结论
- 急性期123I-IMZ SPECT显像中的交叉性小脑示踪剂摄取可预测非致死性高血压性壳核或丘脑出血患者3个月功能结局。
研究设计与样本
- 研究纳入46例非致死性高血压性壳核或丘脑出血患者,于出血后7天内行123I-IMZ早期和晚期SPECT显像。
- 使用三维立体定向感兴趣区模板自动放置双侧小脑半球感兴趣区,计算患侧对侧小脑半球与同侧小脑半球比值(ARcbl)。
- 于出血后3个月采用改良Rankin量表(mRS)评分评估身体功能。
主要发现
- 早期图像ARcbl与3个月mRS评分相关(ρ=-0.511,P=0.0003)。
- 晚期图像ARcbl与3个月mRS评分相关(ρ=-0.714,P<0.0001)。
- 多因素分析显示仅晚期图像低ARcbl与不良功能结局(3个月mRS评分≥3)显著相关(95%CI 0.001-0.003,P=0.0212)。
关键数值与推荐
- 不良功能结局定义为3个月mRS评分≥3。
- ARcbl为患侧对侧小脑半球与同侧小脑半球感兴趣区值的比值。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Whereas SPECT images obtained 180 minutes after administration of I-iomazenil (IMZ) (late images) are proportional to the distribution of central benzodiazepine receptor-binding potential, SPECT images obtained within 30 minutes after I-IMZ administration (early images) correlate with regional brain perfusion. The aim of the present study was to determine whether crossed cerebellar tracer uptake on acute-stage I-IMZ SPECT imaging predicts 3-month functional outcome in patients with nonfatal hypertensive putaminal or thalamic hemorrhage. METHODS: Forty-six patients underwent early and late SPECT imaging with I-IMZ within 7 days after the onset of hemorrhage. A region of interest was automatically placed in the bilateral cerebellar hemispheres using a 3-dimensional stereotaxic region-of-interest template, and the ratio of the value in the cerebellar hemisphere contralateral to the affected side to that in the ipsilateral cerebellar hemisphere (ARcbl) was calculated in each patient. Each patient's physical function was measured using the modified Rankin scale (mRS) score 3 months after onset. RESULTS: The ARcbl on early (ρ = -0.511, P = 0.0003) and late (ρ = -0.714, P < 0.0001) images correlated with the mRS 3 months after the onset of hemorrhage. Multivariate analysis showed that only a low ARcbl in late images was significantly associated with a poor functional outcome (mRS score ≥3 at 3 months after onset) (95% confidence interval, 0.001-0.003; P = 0.0212). CONCLUSIONS: Crossed cerebellar tracer uptake on acute-stage I-IMZ SPECT imaging predicts 3-month functional outcome in patients with nonfatal hypertensive putaminal or thalamic hemorrhage.
引用
- Kojima D, Komoribayashi N, Omama S, et al. Crossed Cerebellar Tracer Uptake on Acute-Stage 123I-Iomazenil SPECT Imaging Predicts 3-Month Functional Outcome in Patients With Nonfatal Hypertensive Putaminal or Thalamic Hemorrhage. Clin Nucl Med. 2018. PMID: 29538036. doi:10.1097/RLU.0000000000002068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。